Benefit of pegylated interferon-α-2a/ribavirin in a patient with common variable immunodeficiency and hepatitis C virus cirrhosis after liver transplantation and splenic embolization [1]

Transplantation

Volumn 82, Issue 2, 2006, Pages 289-290

  Foruny, José R ^a   Bárcena, Rafael ^a   Moreno, Ana ^a   Blázquez, Javier ^a   Manzano, Rebeca ^a   Gil Grande, Luis A ^a   Moreno, Alberto ^a   Nuño, Javier ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GANCICLOVIR; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; PEGINTERFERON ALPHA2A; PREDNISONE; RIBAVIRIN;

ADULT; ARTIFICIAL EMBOLISM; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE SEVERITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SPLEEN; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC DEFICIENCY SYNDROMES; INTERFERON ALFA-2A; LIVER TRANSPLANTATION; MALE; POLYETHYLENE GLYCOLS; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 33746391861     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000226223.95971.e7     Document Type: Letter

References (18)

1. Spickett GP, Misbah SA, Chapel HM. Primary antibody deficiency in adults. Lancet 1991; 337: 281.
2. Sneller MC. Common variable immunodeficiency. Am J Med Sci 2001; 321: 42.
3. Healey CJ, Sabharwal NK, Daub J, et al. Outbreak of acute hepatitis C following the use of anti-hepatitis C virus-screened intravenous immunoglobulin therapy. Gastroenterology 1996; 110: 1120.
4. Bjoro K, Froland SS, Yun Z, et al. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N Engl J Med 1994; 331: 1607.
5. Rossi G, Tucci A, Cariani E, et al. Outbreak of hepatitis C virus infection in patients with hematologic disorders treated with intravenous immunoglobulins: different prognosis according to the immune status. Blood 1997; 90: 1309.
6. Bjoro K, Skaug K, Haaland T, Froland SS. Long-term outcome of chronic hepatitis C virus infection in primary hypogammaglobulinaemia. QJM 1999; 92: 433.
7. Smith MS, Webster AD, Dhillon AP, et al. Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency. Gastroenterology 1995; 108: 879.
8. Gow PJ, Mutimer D. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency. Transpl Int 2002; 15: 380.
9. Miller BW, Brennan DC, Korenblat PE, et al. Common variable immunodeficiency in a renal transplant patient with severe recurrent bacterial infection: a case report and review of the literature. Am J Kidney Dis 1995; 25: 947.
10. Hill AT, Thompson RA, Wallwork J, Stableforth DE. Heart-lung transplantation in a patient with end-stage lung disease due to common variable immunodeficiency. Thorax 1998; 53: 622.
11. http://www.unos.org/resources/MeldPeldCalculator.asp?index=98.
12. Singh N. The current management of infectious diseases in the liver transplant recipient. Clin Liver Dis 2000; 4: 657-73.
13. Berenguer M, Ferrell L, Watson J, et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. J Hepatol 2000; 32: 673.
14. Sanchez-Fueyo A, Restrepo JC, Quinto L, et al. Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft. Transplantation 2002; 73: 56-63.
15. Forman LM, Lewis JD, Berlin JA, et al. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889.
16. Biggins SW, Terrault NA. Treatment of recurrent hepatitis C after liver transplantation. Clin Liver Dis 2005; 9: 505.
17. Bloch-Michel C, Viallard JF, Blanco P, et al. Common variable immunodeficiency: 17 observations in the adult. Rev Med Interne 2003; 24: 640.
18. Bárcena R, Gil-Grande L, Moreno J, et al. Partial splenic embolization tor the treatment of hypersplenism in liver transplanted patients with hepatitis C virus recurrence before peg-interferon plus ribavirin. Transplantation 2005; 79: 1634-5.